144 related articles for article (PubMed ID: 3807650)
1. Effect of monofluoromethyldopa (MFMD) on trace amine levels.
Dyck LE
Life Sci; 1987 Feb; 40(6):571-5. PubMed ID: 3807650
[TBL] [Abstract][Full Text] [Related]
2. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor.
Dyck LE
Life Sci; 1989; 44(17):1149-56. PubMed ID: 2716465
[TBL] [Abstract][Full Text] [Related]
3. Reversible, amine--selective effects of acute and chronic brofaromine treatment in the rat.
Dyck LE; Boulton AA
Life Sci; 1992; 51(1):59-66. PubMed ID: 1614274
[TBL] [Abstract][Full Text] [Related]
4. Depression of sympathetic nervous function by DL-alpha-monofluoromethyldopa, an enzyme-activated, irreversible inhibitor of L-aromatic amino acid decarboxylase.
Fozard JR; Spedding M; Palfreyman MG; Wagner J; Möhring J; Koch-Weser J
J Cardiovasc Pharmacol; 1980; 2(3):229-45. PubMed ID: 6156322
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the inhibition of monoamine synthesis by monofluoromethyldopa.
Bey P; Jung MJ; Koch-Weser J; Palfreyman MG; Sjoerdsma A; Wagner J; Zraïka M
Br J Pharmacol; 1980 Dec; 70(4):571-6. PubMed ID: 7470730
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of intraventricularly injected trace amines and their deuterated isotopomers.
Durden DA; Nguyen TV; Boulton AA
Neurochem Res; 1988 Oct; 13(10):943-50. PubMed ID: 3216952
[TBL] [Abstract][Full Text] [Related]
7. Effect of alpha-methyl fluorodopa on dopamine metabolites: importance of conjugation and egress.
Sarna GS; Hutson PH; Curzon G
Eur J Pharmacol; 1984 May; 100(3-4):343-50. PubMed ID: 6203763
[TBL] [Abstract][Full Text] [Related]
8. Anatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cord.
Gozal EA; O'Neill BE; Sawchuk MA; Zhu H; Halder M; Chou CC; Hochman S
Front Neural Circuits; 2014; 8():134. PubMed ID: 25426030
[TBL] [Abstract][Full Text] [Related]
9. Effects of tranylcypromine on the concentration of some trace amines in the diencephalon and hippocampus of the rat.
Philips SR; Baker GB; McKim HR
Experientia; 1980 Feb; 36(2):241-2. PubMed ID: 7371771
[TBL] [Abstract][Full Text] [Related]
10. Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.
Johansson P; Henning M
Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):28-31. PubMed ID: 7144925
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
Palfreyman MG; McDonald IA; Fozard JR; Mely Y; Sleight AJ; Zreika M; Wagner J; Bey P; Lewis PJ
J Neurochem; 1985 Dec; 45(6):1850-60. PubMed ID: 3840523
[TBL] [Abstract][Full Text] [Related]
12. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain.
Silkaitis RP; Mosnaim AD
Brain Res; 1976 Sep; 114(1):105-15. PubMed ID: 963535
[TBL] [Abstract][Full Text] [Related]
13. A method for measuring monoamine turnover in animals using an irreversible inhibitor of aromatic L-amino acid decarboxylase, DL-alpha-mono fluoromethyldopa.
Palfreyman MG; Zreika M; Arbogast R; Wagner J
J Pharmacol Methods; 1984 Jul; 11(4):239-51. PubMed ID: 6204167
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aromatic amino acid decarboxylase and depletion of biogenic amines in brain of rats treated with alpha-monofluoromethyl p-tyrosine: similitudes and differences with the effects of alpha-monofluoromethyldopa.
Jung MJ; Hornsperger JM; Gerhart F; Wagner J
Biochem Pharmacol; 1984 Jan; 33(2):327-30. PubMed ID: 6704155
[No Abstract] [Full Text] [Related]
15. The presence of tyramine and related monoamines in the nerve cord and some other tissues of the lobster, Homarus americanus.
Juorio AV; Sloley BD
Brain Res; 1988 Mar; 444(2):380-2. PubMed ID: 3359304
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of monoamine synthesis by irreversible blockade of aromatic aminoacid decarboxylase with alpha-monofluoromethyldopa.
Jung MJ; Palfreyman MG; Wagner J; Bey P; Ribereau-Gayon G; Zraïka M; Koch-Weser J
Life Sci; 1979 Mar; 24(11):1037-42. PubMed ID: 449607
[No Abstract] [Full Text] [Related]
17. Mechanism of the antihypertensive action of DL-alpha-monofluoromethyldopa: implications for the role of the sympathetic nervous system in maintenance of elevated blood pressure in spontaneously hypertensive rats.
Fozard JR; Möhring J; Palfreyman MG; Koch-Weser J
J Cardiovasc Pharmacol; 1981; 3(5):1038-49. PubMed ID: 6168849
[TBL] [Abstract][Full Text] [Related]
18. Cerebral decarboxylation of meta- and para-tyrosine.
Boulton AA; Juorio AV
Experientia; 1983 Feb; 39(2):130-4. PubMed ID: 6832285
[TBL] [Abstract][Full Text] [Related]
19. The biosynthesis of p-tyramine, m-tyramine, and beta-phenylethylamine by rat striatal slices.
Dyck LE; Yang CR; Boulton AA
J Neurosci Res; 1983; 10(2):211-20. PubMed ID: 6632007
[TBL] [Abstract][Full Text] [Related]
20. Use of D,L-alpha-monofluoromethyldopa to distinguish subcellular pools of aromatic amino acid decarboxylase in mouse brain.
Gardner CR; Richards MH
Brain Res; 1981 Jul; 216(2):291-8. PubMed ID: 6166354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
